Table 2 AI prediction of CHD overall. Maternal saliva metabolomics, clinical and demographic markers- Cross Validation approach (all CHD versus Controls) - Test Group (25 metabolite only model).
SVM | GLM | PAM | RF | LDA | DL | Ensemble | |
|---|---|---|---|---|---|---|---|
AUC 95% CI | 0.8311 (0.6000-1) | 0.8275 (0.6000-1) | 0.8240 (0.6000-1) | 0.8399 (0.6000-1) | 0.8122 (0.6000-1) | 0.8411 (0.6300-1) | 0.8488 (0.6350-1) |
Sensitivity | 0.9050 | 0.9150 | 0.9000 | 0.9000 | 0.9050 | 0.9200 | 0.9250 |
Specificity | 0.8700 | 0.8600 | 0.8750 | 0.8800 | 0.8680 | 0.9100 | 0.9100 |